Magic mushroom therapy could help cancer survivors beat depression

NCT ID NCT06801041

First seen Jun 24, 2026 · Last updated Aug 13, 2026 · Updated 5 times

Summary

This study tests whether psilocybin, the active ingredient in magic mushrooms, combined with talk therapy can safely help cancer survivors with depression or anxiety. Twenty adults who have finished cancer treatment and have no brain involvement will receive a single dose of psilocybin in a supervised outpatient setting. Researchers will track side effects and mood changes to see if this approach is feasible and worth studying further.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
psilocybin
What this could lead to
If it works, this could offer a new way to ease depression and anxiety in cancer survivors, improving their quality of life.
What could go wrong
This is a small, early-phase trial with only 20 participants, so results may not apply to everyone. Psilocybin can cause temporary psychological distress or side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Texas M. D. Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.